The compound N-piperidinyl-[8-chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydrobenzo [6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide] (NESS 0327) was synthesized and evaluated for binding affinity toward cannabinoid CB 1 and CB 2 receptor. NESS 0327 exhibited a stronger selectivity for CB 1 receptor compared with, showing a much higher affinity for CB 1 receptor (K i ϭ 350 Ϯ 5 fM and 1.8 Ϯ 0.075 nM, respectively) and a higher affinity for the CB 2 receptor (K i ϭ 21 Ϯ 0.5 nM and 514 Ϯ 30 nM, respectively). Affinity ratios demonstrated that NESS 0327 was more than 60,000-fold selective for the CB 1 receptor, whereas SR 141716A only 285-fold. NESS 0327 alone did not produce concentration-dependent stimulation of guanosine 5Ј-O-(3-[ Interest in the pharmacology of cannabinoids (CBs) has rapidly increased after the cloning of cannabinoid receptors and the discovery of their endogenous ligand: arachidonylethanolamide (anandamide) (Devane et al., 1988(Devane et al., , 1992Munro et al., 1993). Two types of cannabinoid receptors, CB 1 and CB 2 , have been characterized, both of which have distinct anatomical distributions and ligand binding profiles. Cannabinoid CB 1 receptors are present in the central nervous system with the highest densities in the hippocampus, cerebellum, and striatum (Herkenham et al., 1990;Howlett, 1998), and to a lesser extent in several peripheral tissues. Cannabinoid CB 2 receptors seem to be predominantly located in peripheral tissues (Pertwee, 1997(Pertwee, , 1999Galiègue et al., 1995). Both receptors belong to the G protein-coupled family of receptors that negatively regulate adenylate cyclase and control the release of arachidonic acid (Howlett, 1995). Naturally occurring [⌬ 9 -tetrahydrocannabinol (⌬ 9 -THC) and ⌬ 8 -THC] and synthetic cannabinoid agonists CP 55,940, and WIN 55, produce a number of effects in mice (hypoactivity, catalepsy, hypothermia, and antinociception) that are collectively known as the tetrad of cannabinoidinduced behaviors (Abood and Martin, 1992;Compton et al., 1992Compton et al., , 1993. These behaviors are of a central origin and are thought to be mediated via the cannabinoid CB 1 receptor (Rinaldi-Carmona et al., 1994;Compton et al., 1996;Lichtman and Martin, 1997), whereas the CB 2 receptor may mediate some of the peripheral effects of ⌬ 9 -THC, such as immunosuppression (Martin, 1986).The cloning of CB 1 and CB 2 receptors and the subsequent development of selective tools have advanced the concept of Article, publication date, and citation information can be found at